{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:38:06Z","timestamp":1760204286235,"version":"3.33.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ejphar.2008.02.056","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T13:49:21Z","timestamp":1205416161000},"page":"306-312","source":"Crossref","is-referenced-by-count":9,"title":["Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses"],"prefix":"10.1016","volume":"586","author":[{"given":"Hiroshi","family":"Tsuchida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Mukaiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.02.056_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0110001","article-title":"Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids","volume":"11","author":"Adcock","year":"1993","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(02)02124-6","article-title":"SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist","volume":"450","author":"Anthes","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejphar.2008.02.056_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjp.0706198","article-title":"Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway","volume":"145","author":"Bardelli","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(86)90777-4","article-title":"Asthma as an axon reflex","volume":"1","author":"Barnes","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.02.056_bib6","doi-asserted-by":"crossref","first-page":"R454","DOI":"10.1152\/ajpregu.00862.2005","article-title":"Mechanistic studies of acid-evoked coughing in anesthetized guinea pigs","volume":"291","author":"Canning","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib7","first-page":"480","article-title":"Tachykinins in the lungs","volume":"11","author":"Chapman","year":"1998","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ejphar.2008.02.056_bib8","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1067\/mai.2000.109829","article-title":"Substance P and its receptor neurokinin 1 expression in asthmatic airways","volume":"106","author":"Chu","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1474-8673.2003.00279.x","article-title":"Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig","volume":"23","author":"Corboz","year":"2003","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1164\/ajrccm.158.1.9705052","article-title":"Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs","volume":"158","author":"Daoui","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2008.02.056_bib12","doi-asserted-by":"crossref","first-page":"PL101","DOI":"10.1016\/0024-3205(92)90352-P","article-title":"A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor","volume":"50","author":"Emonds-Alt","year":"1992","journal-title":"Life Sci."},{"issue":"Suppl.","key":"10.1016\/j.ejphar.2008.02.056_bib13","first-page":"1","article-title":"The biological standardization of insulin","volume":"7","author":"Fieller","year":"1940","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.ejphar.2008.02.056_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1476-5381.1992.tb14524.x","article-title":"Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888","volume":"107","author":"Fujii","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/13543776.7.4.307","article-title":"Neurokinin-3 receptor antagonists","volume":"7","author":"Giardina","year":"1997","journal-title":"Exp. Opin. Ther. Patents"},{"key":"10.1016\/j.ejphar.2008.02.056_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/thx.53.5.357","article-title":"Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects","volume":"53","author":"Heaney","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2008.02.056_bib17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1096\/fasebj.4.6.1969374","article-title":"Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms","volume":"4","author":"Helke","year":"1990","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2008.02.056_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0306-4522(86)90024-2","article-title":"Capsaicin induced release of multiple tachykinins (substance P, neurokinin A and eledoisin-like material) from guinea-pig spinal cord and ureter","volume":"19","author":"Hua","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2008.02.056_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1749-6632.2003.tb03152.x","article-title":"The role of neural inflammation in asthma and chronic obstructive pulmonary disease","volume":"992","author":"Joos","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2008.02.056_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/pulp.1996.0041","article-title":"The role of capsaicin-sensitive C-fibre afferent nerves in the cough reflex","volume":"9","author":"Karlsson","year":"1996","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1152\/jappl.1988.65.3.1007","article-title":"Afferent neural pathways in cough and reflex bronchoconstriction","volume":"65","author":"Karlsson","year":"1988","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01861842","article-title":"Versuchsanordnung zu Untersuchungen an der Bronchialmuskulatur","volume":"195","author":"Konzett","year":"1940","journal-title":"Arch. Exp. Pathol. Pharmakol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib23","first-page":"840","article-title":"In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1\/NK-2 tachykinin receptor antagonist","volume":"277","author":"Kudlacz","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.02.056_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1476-5381.1993.tb13640.x","article-title":"Postjunctional inhibitory effect of the NK2 receptor antagonist, SR 48968, on sensory NANC bronchoconstriction in the guinea-pig","volume":"109","author":"Lou","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(94)E0017-B","article-title":"Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves","volume":"45","author":"Maggi","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-0115(97)00029-3","article-title":"The effects of tachykinins on inflammatory and immune cells","volume":"70","author":"Maggi","year":"1997","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2008.02.056_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1474-8673.1993.tb00396.x","article-title":"Tachykinin receptors and tachykinin receptor antagonists","volume":"13","author":"Maggi","year":"1993","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00151829-200403040-00001","article-title":"Targeting tachykinins for the treatment of obstructive airways disease","volume":"3","author":"Mazzone","year":"2004","journal-title":"Treat. Respir. Med."},{"key":"10.1016\/j.ejphar.2008.02.056_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejphar.2004.07.071","article-title":"Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea pig model","volume":"498","author":"Mukaiyama","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1164\/rccm.200405-600OC","article-title":"A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons","volume":"171","author":"Myers","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2008.02.056_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0091-6749(92)90138-R","article-title":"Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma","volume":"90","author":"Nieber","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib32","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0960-894X(00)00324-3","article-title":"Combined tachykinin receptor antagonist: synthesis and stereochemical structure-activity relationships of novel morpholine analogues","volume":"10","author":"Nishi","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2008.02.056_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1152\/physrev.1993.73.2.229","article-title":"Neurotransmitter functions of mammalian tachykinins","volume":"73","author":"Otsuka","year":"1993","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2008.02.056_bib34","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.lfs.2003.09.039","article-title":"Tachykinins and tachykinin receptors: a growing family","volume":"74","author":"Pennefather","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.02.056_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.bjp.0705029","article-title":"Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands","volume":"138","author":"Phillips","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1476-5381.1988.tb11745.x","article-title":"Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs","volume":"95","author":"Rogers","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3565(24)29382-4","article-title":"Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors","volume":"298","author":"Rumsey","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.02.056_bib38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.2042-7158.1995.tb03270.x","article-title":"Involvement of NK1 and NK2 receptors in pulmonary responses elicited by non-adrenergic, non-cholinergic vagal stimulation in guinea-pigs","volume":"47","author":"Savoie","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.056_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pupt.2005.10.007","article-title":"The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma","volume":"19","author":"Schelfhout","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.02.056_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/pr.54.2.285","article-title":"The tachykinin peptide family","volume":"54","author":"Severini","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2008.02.056_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(95)00881-0","article-title":"Effects of specific tachykinin receptor antagonists on citric acid-induced cough and bronchoconstriction in unanesthetized guinea pigs","volume":"300","author":"Yasumitsu","year":"1996","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T02:57:53Z","timestamp":1738119473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0014299908002422"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.02.056","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}